Salimetrics

Executive Summary

Salimetrics is a pioneering company in salivary bioscience, established in 1998 and headquartered in Carlsbad, California. It offers a comprehensive suite of saliva collection devices, immunoassay kits, and CLIA-certified laboratory testing services for both research and clinical applications. By enabling non-invasive biomarker analysis, Salimetrics serves the biobehavioral and clinical research markets, providing validated tools that support studies in stress, inflammation, neurology, and other fields. Its products are widely used in academic, pharmaceutical, and government research, and the company's CLIA lab ensures high-quality, reproducible results for diagnostic use. Despite being a private company with limited public financial information, Salimetrics holds a strong position in a niche but growing market. The increasing demand for non-invasive diagnostic methods and the expansion of biomarker research present significant growth opportunities. Salimetrics is well-positioned to capitalize on trends toward at-home testing and personalized medicine. However, its private status and dependence on research funding cycles introduce some uncertainty. Overall, the company's established reputation, extensive product portfolio, and regulatory capabilities underpin its stability and potential for steady growth.

Upcoming Catalysts (preview)

• Q2 2026Launch of new multiplex salivary assay panels for inflammation and neurology75% success
• Q4 2026Partnership or collaboration with a major pharmaceutical company for decentralized clinical trials60% success
• Q3 2026FDA clearance or CLIA certification expansion for a novel diagnostic test50% success